Unicycive Therapeutics, Inc. (UNCY)
5.19
+0.14
(+2.77%)
USD |
NASDAQ |
Sep 02, 16:00
5.24
+0.05
(+0.96%)
Pre-Market: 08:13
Unicycive Therapeutics Research and Development Expense (TTM) : 9.609M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.609M |
| March 31, 2026 | 8.571M |
| December 31, 2025 | 9.135M |
| September 30, 2025 | 12.17M |
| June 30, 2025 | 12.25M |
| March 31, 2025 | 15.37M |
| December 31, 2024 | 20.01M |
| September 30, 2024 | 18.96M |
| June 30, 2024 | 19.29M |
| March 31, 2024 | 16.68M |
| December 31, 2023 | 12.90M |
| September 30, 2023 | 12.51M |
| June 30, 2023 | 13.94M |
| Date | Value |
|---|---|
| March 31, 2023 | 13.53M |
| December 31, 2022 | 12.44M |
| September 30, 2022 | 9.957M |
| June 30, 2022 | 8.93M |
| March 31, 2022 | 7.563M |
| December 31, 2021 | 6.08M |
| September 30, 2021 | 5.101M |
| June 30, 2021 | 1.629M |
| March 31, 2021 | 1.317M |
| December 31, 2020 | 1.015M |
| September 30, 2020 | 1.009M |
| June 30, 2020 | 0.893M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Theriva Biologics, Inc. | 5.306M |
| AbbVie, Inc. | 9.714B |
| Decoy Therapeutics, Inc. | 2.230M |
| Nkarta, Inc. | 89.88M |